We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
-12.48%
1 Year Est. Return
+57.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.83B
AUM Growth
-$552M
Cap. Flow
-$213M
Cap. Flow %
-11.65%
Top 10 Hldgs %
38.36%
Holding
393
New
26
Increased
32
Reduced
188
Closed
35

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$37.8M
2
JPM icon
JPMorgan Chase
JPM
+$22.4M
3
NVDA icon
NVIDIA
NVDA
+$16.3M
4
HD icon
Home Depot
HD
+$15.5M
5
LLY icon
Eli Lilly
LLY
+$13.5M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Healthcare 17.43%
3 Consumer Discretionary 11.59%
4 Industrials 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REX icon
201
REX American Resources
REX
$1.43B
$119K 0.01%
15,300
GTS
202
DELISTED
Triple-S Management Corporation
GTS
$119K 0.01%
8,424
FISI icon
203
Financial Institutions
FISI
$814M
$114K 0.01%
6,260
BPMC
204
DELISTED
Blueprint Medicines
BPMC
$111K 0.01%
1,890
MIXT
205
DELISTED
MIX TELEMATICS LIMITED
MIXT
$110K 0.01%
12,671
NIC icon
206
Nicolet Bankshares
NIC
$3.63B
$109K 0.01%
2,000
BRK.B icon
207
Berkshire Hathaway Class B
BRK.B
$1.13T
$108K 0.01%
592
-49
-8% -$10.4K
TPCO
208
DELISTED
Tribune Publishing Company Common Stock
TPCO
$108K 0.01%
13,278
ANGO icon
209
AngioDynamics
ANGO
$651M
$107K 0.01%
10,251
MED icon
210
Medifast
MED
$135M
$105K 0.01%
1,684
WRLD icon
211
World Acceptance Corp
WRLD
$871M
$105K 0.01%
1,930
EBS icon
212
Emergent Biosolutions
EBS
$229M
$104K 0.01%
1,790
GBT
213
DELISTED
Global Blood Therapeutics, Inc.
GBT
$102K 0.01%
2,000
CVI icon
214
CVR Energy
CVI
$3.26B
$98K 0.01%
5,904
PTCT icon
215
PTC Therapeutics
PTCT
$6.23B
$98K 0.01%
2,200
ARWR icon
216
Arrowhead Research
ARWR
$12.5B
$97K 0.01%
3,360
FBM
217
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$97K 0.01%
9,440
-16,980
-64% -$276K
HALO icon
218
Halozyme
HALO
$11.6B
$96K 0.01%
5,350
TLYS icon
219
Tilly's
TLYS
$130M
$96K 0.01%
23,325
PFC
220
DELISTED
Premier Financial Corp. Common Stock
PFC
$91K 0.01%
6,142
RARE icon
221
Ultragenyx Pharmaceutical
RARE
$2.64B
$89K ﹤0.01%
2,000
MNTA
222
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$86K ﹤0.01%
3,150
KYNB
223
Kyntra Bio
KYNB
$28.2M
$84K ﹤0.01%
96
-1
-1% -$994
SNBR
224
DELISTED
Sleep Number
SNBR
$80K ﹤0.01%
4,180
+1,570
+60% +$69.9K
TITN icon
225
Titan Machinery
TITN
$426M
$80K ﹤0.01%
9,243

Similar funds

Smith Group Asset Management's Q1 2020 Portfolio in Review

As of Q1 2020, Smith Group Asset Management held 393 positions worth $1.83B, down 23% from $2.38B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Smith Group Asset Management withdrew a net $213M in Q1 2020, closing 35 positions and reducing 188 holdings. Its most notable exit was VF Corp, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Smith Group Asset Management opened a new position in Home Depot worth $13.2M.

  • Smith Group Asset Management's largest Q1 2020 buy was Home Depot: 70,570 shares worth $13.2M.
  • Smith Group Asset Management added most to Amazon in Q1 2020, an estimated $37.8M increase.
  • Smith Group Asset Management's biggest Q1 2020 reduction was Meta Platforms (Facebook), cutting an estimated $28.8M.
  • Smith Group Asset Management fully exited VF Corp in Q1 2020, selling an estimated $25.6M.
  • Smith Group Asset Management's ten largest holdings make up 38% of its $1.83B portfolio in Q1 2020.
  • Smith Group Asset Management opened 26 new positions and closed 35 in Q1 2020.
  • Smith Group Asset Management's portfolio value fell 23% quarter-over-quarter to $1.83B.

Based on Smith Group Asset Management's 13F filing for Q1 2020, filed 12 May 2020.